NMRK Stock Analysis: Newmark | NASDAQ
Real Estate Services | NASDAQ, USA | Market Cap: 2.903m USD | 12M Return: -33.4% | US65158N1028 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.4M
EPS Trend: 99.3%
Qual. Beats: 0
Rev. Trend: 99.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Newmark Group, Inc. (NMRK) is a global commercial real estate advisor and service provider operating across the United States, the United Kingdom, Asia, Europe, and the Americas. The company offers a diversified range of services, including capital markets (investment sales, commercial mortgage brokerage, and structured finance), landlord and tenant representation leasing, multifamily loan servicing, valuation and advisory, property management, workspace solutions, occupier services, and business rates consulting. Its clients span commercial real estate tenants, investors, owners, occupiers, developers, lenders, small and medium-sized businesses, multinational corporations, and institutional owners.
The firm was founded in 1929, is headquartered in New York, and operates as a subsidiary of Cantor Fitzgerald, L.P. It went public in December 2017, having previously been known as Newmark Grubb Knight Frank Capital Group. Within the real estate sector, Newmark competes alongside other diversified CRE services firms such as CBRE, JLL, and Cushman & Wakefield, distinguishing itself through its broad service portfolio that spans both capital markets transactions and ongoing property and facilities management.
- CRE transaction volumes hinge on Fed rate path
- Office leasing weakness persists amid hybrid work trends
- GSE multifamily lending and servicing fees expand
- Special dividends continue under Cantor Fitzgerald ownership
| Net Income: 148.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 20.14 > 1.0 |
| NWC/Revenue: 5.00% < 20% (prev 2.84%; Δ 2.15% < -1%) |
| CFO/TA 0.16 > 3% & CFO 846.0m > Net Income 148.2m |
| Net Debt (2.41b) to EBITDA (495.7m): 4.86 < 3 |
| Current Ratio: 1.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.9m) vs 12m ago 0.11% < -2% |
| Gross Margin: 94.97% > 18% (prev 100.0%; Δ -5.03% > 0.5%) |
| Asset Turnover: 68.16% > 50% (prev 55.35%; Δ 12.81% > 0%) |
| Interest Coverage Ratio: 4.84 > 6 (EBIT TTM 311.2m / Interest Expense TTM 64.3m) |
| A: 0.03 (Total Current Assets 2.10b - Total Current Liabilities 1.92b) / Total Assets 5.19b |
| B: 0.26 (Retained Earnings 1.33b / Total Assets 5.19b) |
| C: 0.06 (EBIT TTM 311.2m / Avg Total Assets 5.29b) |
| D: 0.42 (Book Value of Equity 1.45b / Total Liabilities 3.44b) |
| Altman-Z'' = 1.90 = BBB |
| DSRI: 0.91 (Receivables 660.1m/598.7m, Revenue 3.61b/2.98b) |
| GMI: 1.05 (GM 100.0% / 94.97%) |
| AQI: 1.09 (AQ_t 0.49 / AQ_t-1 0.44) |
| SGI: 1.21 (Revenue 3.61b / 2.98b) |
| TATA: -0.13 (NI 148.2m - CFO 846.0m) / TA 5.19b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of October 17, 2026, the stock is trading at USD 11.86 with a total of 1,429,101 shares traded. Over the past week, the price has changed by -2.15%, over one month by -16.42%, over three months by -25.11% and over the past year by -33.37%.
Current recommended Stop Loss: 11.20 (which is 5.6% or 1.3 ATR below the current price).
Newmark has received a consensus analysts rating of 4.14. Therefore, it is recommended to buy NMRK.
- StrongBuy: 2
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 18.3 | 54.6% |
P/E Trailing = 15.0127
P/E Forward = 5.7405
P/S = 0.8053
P/B = 1.6564
Revenue TTM = 3.61b USD
EBIT TTM = 311.2m USD
EBITDA TTM = 495.7m USD
Long Term Debt = 867.3m USD (from longTermDebt, last quarter)
Short Term Debt = 909.1m USD (from shortTermDebt, last quarter)
Debt = 2.67b USD (from shortLongTermDebtTotal, last quarter) + Leases 494.7m
Net Debt = 2.41b USD (calculated: Debt 2.67b - CCE 259.7m)
Enterprise Value = 5.31b USD (2.90b + Debt 2.67b - CCE 259.7m)
Interest Coverage Ratio = 4.84 (Ebit TTM 311.2m / Interest Expense TTM 64.3m)
EV/FCF = 6.66x (Enterprise Value 5.31b / FCF TTM 797.6m)
FCF Yield = 15.02% (FCF TTM 797.6m / Enterprise Value 5.31b)
FCF Margin = 22.12% (FCF TTM 797.6m / Revenue TTM 3.61b)
Net Margin = 4.11% (Net Income TTM 148.2m / Revenue TTM 3.61b)
Gross Margin = 94.97% ((Revenue TTM 3.61b - Cost of Revenue TTM 181.3m) / Revenue TTM)
Gross Margin QoQ = 94.82% (prev 94.54%)
Tobins Q-Ratio = 1.02 (Enterprise Value 5.31b / Total Assets 5.19b)
Interest Expense / Debt = 2.41% (Interest Expense 64.3m / Debt 2.67b)
Taxrate = 26.30% (64.9m / 246.8m)
NOPAT = 229.3m (EBIT 311.2m * (1 - 26.30%))
Current Ratio = 1.09 (Total Current Assets 2.10b / Total Current Liabilities 1.92b)
Debt / Equity = 1.84 (Debt 2.67b / totalStockholderEquity, last quarter 1.45b)
Debt / EBITDA = 4.86 (Net Debt 2.41b / EBITDA 495.7m)
Debt / FCF = 3.02 (Net Debt 2.41b / FCF TTM 797.6m)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.80% (Net Income 148.2m / Total Assets 5.19b)
RoE = 10.45% (Net Income TTM 148.2m / Total Stockholder Equity 1.42b)
RoCE = 13.61% (EBIT 311.2m / Capital Employed (Equity 1.42b + L.T.Debt 867.3m))
RoIC = 5.74% (NOPAT 229.3m / Invested Capital 4.00b)
WACC = 6.14% (E(2.90b)/V(5.57b) * Re(10.16%) + D(2.67b)/V(5.57b) * Rd(2.41%) * (1-Tc(0.26)))
Discount Rate = 10.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 43.60 | Cagr: 18.06%
[DCF] Terminal Value 75.44% ; FCFF base≈797.6m ; Y1≈800.9m ; Y5≈848.4m
[DCF] Fair Price = 67.44 (EV 13.2b - Net Debt 2.41b = Equity 10.8b / Shares 159.9m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 99.31 | EPS CAGR: 26.95% | SUE: -0.43 | # QB: 0
Revenue Correlation: 99.09 | Revenue CAGR: 17.19% | SUE: 0.71 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.47 | Chg30d=-1.05% | Revisions=-38% | Analysts=6
EPS current Year (2026-12-31): EPS=1.94 | Chg30d=-0.80% | Revisions=+38% | GrowthEPS=+19.6% | GrowthRev=+15.6%
EPS next Year (2027-12-31): EPS=2.17 | Chg30d=-1.69% | Revisions=+44% | GrowthEPS=+12.0% | GrowthRev=+8.5%
[Analyst] Revisions Ratio: +21% (up=10, down=6)